Evaluation of serum and urinary angiogenic factors in patients with endometriosis

被引:57
作者
Cho, Si Hyun
Oh, Yoon Jin
Nam, Anna
Kim, Hye Yeon
Park, Joo Hyun
Kim, Jae Hoon
Park, Ki Hyun
Cho, Dong Je
Lee, Byung Seok
机构
[1] Yonsei Univ, Coll Med, Yongdong Severance Hosp, Dept Obstet & Gynecol, Seoul 135720, South Korea
[2] Yonsei Univ, Coll Med, Severance Hosp, Dept Obstet & Gynecol, Seoul 135720, South Korea
[3] Yonsei Univ, Coll Med, Yongdong Severance Hosp, Dept Obstet & Gynecol, Yongin, Kyunggi Do, South Korea
关键词
endometriosis; serum; sFlt-1; TNF-alpha; urine; VEGF;
D O I
10.1111/j.1600-0897.2007.00535.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Problem The aim of this study was to evaluate serum and urinary levels of vascular endothelial growth factors, tumor necrosis factor-alpha (TNF-alpha), and soluble fms-like tyrosine kinase (sFlt-1) in patients with endometriosis. Method of study During surgery for pelvic pain, pelvic mass or infertility, serum and urine were collected. Of 70 patients, 46 had histology-proven endometriosis and 24 patients without endometriosis participated as controls. Results Serum TNF-alpha levels and urinary sFlt-1 levels corrected for creatinine excretion were significantly increased in the endometriosis group (P = 0.001 and P = 0.011 respectively). Serum sFlt-1 levels and urinary sFlt-1 levels corrected for creatinine were significantly higher in patients with minimal-to-mild disease (P = 0.014 and P = 0.015 respectively), where serum TNF-alpha levels were increased in moderate-to-severe endometriosis (P < 0.001). Conclusion The pathogenesis of minimal-to-mild endometriosis and moderate-to-severe endometriosis seems to be different. Increased sFlt-1 levels in serum and urine of minimal-to-mild disease indicate that sFlt-1 may have an important role in inhibiting angiogenic process of the disease.
引用
收藏
页码:497 / 504
页数:8
相关论文
共 28 条
[1]   Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come [J].
Aref, S ;
El Sherbiny, M ;
Goda, T ;
Fouda, M ;
Al Askalany, H ;
Abdalla, D .
HEMATOLOGY, 2005, 10 (02) :131-134
[2]   Vascular endothelial growth factor and its soluble receptor in ovarian pathology [J].
Artini, PG ;
Cristello, F ;
Monti, M ;
Cela, V ;
Battaglia, C ;
D'Ambrogio, G ;
Genazzani, AR .
GYNECOLOGICAL ENDOCRINOLOGY, 2005, 21 (01) :50-56
[3]   Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial [J].
Bedaiwy, MA ;
Falcone, T ;
Sharma, RK ;
Goldberg, JM ;
Attaran, M ;
Nelson, DR ;
Agarwal, A .
HUMAN REPRODUCTION, 2002, 17 (02) :426-431
[4]   Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia [J].
Buhimschi, CS ;
Norwitz, ER ;
Funai, E ;
Richman, S ;
Guller, S ;
Lockwood, CJ ;
Buhimschi, IA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 192 (03) :734-741
[5]  
Canis M, 1997, FERTIL STERIL, V67, P817
[6]   A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation [J].
Clark, DE ;
Smith, SK ;
He, YL ;
Day, KA ;
Licence, DR ;
Corps, AN ;
Lammoglia, R ;
Charnock-Jones, DS .
BIOLOGY OF REPRODUCTION, 1998, 59 (06) :1540-1548
[7]   Serum and cyst fluid levels of interleukin (IL)-6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours [J].
Daraï, E ;
Detchev, R ;
Hugol, D ;
Quang, NT .
HUMAN REPRODUCTION, 2003, 18 (08) :1681-1685
[8]   Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy [J].
Dvorak, HF .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (21) :4368-4380
[9]   Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathology [J].
Fasciani, A ;
D'Ambrogio, G ;
Bocci, G ;
Luisi, S ;
Artini, PG ;
Genazzani, AR .
FERTILITY AND STERILITY, 2001, 75 (06) :1218-1221
[10]   Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis [J].
Gagné, D ;
Pagé, M ;
Robitaille, G ;
Hugo, P ;
Gosselin, D .
HUMAN REPRODUCTION, 2003, 18 (08) :1674-1680